Veta-K1 Capsules

This page contains information on Veta-K1 Capsules for veterinary use.
The information provided typically includes the following:
  • Veta-K1 Capsules Indications
  • Warnings and cautions for Veta-K1 Capsules
  • Direction and dosage information for Veta-K1 Capsules

Veta-K1 Capsules

This treatment applies to the following species:
Manufacturer: Bimeda

Vitamin K1, Oral Capsule

Each Capsule contains 25 mg of Phytonadione

Description

Veta-K1 Capsules contain phytonadione with excipients in an artificially colored soft gelatin shell.

ACTIONS:

Veta-K1 Capsules for oral administration possesses the same type and degree of activity as does naturally occurring vitamin K. The primary function of vitamin K is to stimulate the production via the liver of active prothrombin from a precursor protein. The mechanism by which vitamin K promotes formation of prothrombin at the molecular level has not been established.

Veta-K1 Capsules Indications

Veta-K1 Capsules are indicated in dogs and cats to counter hypoprothrombinemia induced by ingestion of coumarin-based compounds, common ingredients of commercial rodenticides, and other drug induced hypoprothrombinemia where it is definitely shown that the result is due to interference with vitamin K metabolism, (e.g. salicylates).

NOTE:

Regular determinations of prothrombin time response should be performed to guide in the initial and subsequent administration of Veta-K1 oral capsules. The dosage should be adjusted accordingly.

CONTRAINDICATION:

Hypersensitivity to any component of this medication.

Warnings

It is recommended that Veta-K1 oral capsules be used in follow-up therapy only after administration of phytonadione injection and hospitalization is no longer required. An immediate coagulant effect should not be expected after administration of phytonadione when administered orally.

Phytonadione will not counteract the anticoagulant action of heparin.

Repeated large doses of vitamin K1 are not warranted in hepatic disease if the response to the initial therapy is unsatisfactory. Failure to respond to vitamin K1 may indicate that the condition being treated is inherently unresponsive to vitamin K1.

Precautions

Protect from light at all times. Temporary resistance to prothrombin-depressing anticoagulants may result, especially when larger doses of phytonadione are used.

DOSAGE AND ADMINISTRATION:

Dogs and cats

Hypoprothrombinemia (with hemorrhage)- Administer orally at the rate of 2.5-5 mg/kg body weight (1 capsule for each 22 pounds of body weight for lower dosage or 1 capsule for each 11 pounds body weight for higher dosage) daily as conditions require up to 3 weeks.

Frequency and amount of oral administration should be guided by regular determination of prothrombin time.

The smallest effective dose should be sought to minimize the risk of adverse reaction.

Veta-K1 Capsules Caution

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

How Supplied

Veta-K1 oral capsules are available in bottles of 50 capsules each.

FOR ANIMAL USE ONLY

KEEP OUT OF REACH OF CHILDREN

Veta-K1 is a Registered Trademark of Bimeda, Inc.

Manufactured by: BEST FORMULATIONS, City of Industry, California 91748

Manufactured for: Bimeda, Inc., Le Sueur, MN 56058

8VET012-609

Net Contents:

Product No.

 

50 Capsules

1VET006

8VET011 Rev: 4/10

NAC No.: 13990445

BIMEDA, INC.
Div. Cross Vetpharm Group, Ltd.

ONE TOWER LANE-SUITE 2250, OAKBROOK TERRACE, IL, 60181
Telephone:   630-928-0361
Fax:   630-928-0362
Website:   www.bimedaus.com
Email:   sales@bimedaus.com
Every effort has been made to ensure the accuracy of the Veta-K1 Capsules information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-12-03

(web1)